Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

(1992): Bennett MJ, JRArmyMedCorps138, 56
(1987): Bryant SG+, Pharmacotherapy 7(4), 125
(1987): Edwards R, NZMedJ100, 640
(1980): Möller H+, Acta Derm Venereol (Stockh) 60, 495
Phototoxicity
(2006): Habif TP, NEnglJMed355(2), 182
(2002): Bohannon JS, Midlothian, VA (from Internet)
(observation)
(2002): Fishman CB, San Luis Obispo, CA (from Internet)
(observation)
(2002): Litt JZ, Beachwood, OH (personal case) (observation)
(2002): Sorkin M, Denver, CO (from Internet) (observation)
(2002): Thaler D, Monona, WI (from Internet) (observation)
(1999): Litt JZ, Beachwood, OH (personal case) (observation)
(1996): McCarty JR, Fort Worth, TX (from Internet)
(observation)
(1995): Smith EL+, Br J Dermatol 132, 316
(1994): Bjellerup AM+, Br J Dermatol 130, 356
(1993): Layton A+, Clin Exp Dermatol 18, 425
(1993): Shea CR+, J Invest Dermatol 101, 329
(1982): Rosen K+, Acta Derm Venereol 62, 246
Pigmentation
(2006): Adisen E+, Int J Dermatol 45(10), 1245
(2006): Pichardo RO+, Am J Dermatopathol A(3), 235
(2002): Bohm M+, Am J Dermatopathol 24(4), 345
(1999): Westermann GW+, J Intern Med 246, 591
(1980): Möller H+, Acta Derm Venereol (Stockh) 60, 495
Pruritus ani et vulvae
Psoriasis
(1988): Tsankov NK+, Australas J Dermatol 29, 111
Purpura
Rash (sic) (